Article
Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie - 1 Mar 2009
Yoshida E M, Sherman M, Bain V G, Cooper C L, Deschênes M, Marotta P J, Lee S S, Krajden M, Witt-Sullivan H, Bailey R J, Usaty C, Peltekian K
Abstract excerpt
BACKGROUND: Pegylated interferon (pegIFN) and ribavirin combination therapy remains the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the wealth of studies in treatment-naive patients, the effectiveness of retreatment in patients who have previously failed pegIFN-based therapy is largely unreported. AIM: To assess the effectiveness of the retreatment of patients who have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.